<p>(A-D) BALF collected from Cre+ and Cre- mice at day 3 following bleomycin administration revealed no significant difference in BALF WBC, RBC, total protein, or cell differential. (E-K) BALF collected from Cre+ and Cre- mice at day 7 following bleomycin administration revealed no significant difference in BALF WBC, RBC, total protein, and cell differential. Measurements of select inflammatory cytokines in BALF revealed elevation of CXCL1 in Cre+ compared to Cre- animals but no difference in CXCL10 or MCP-1 (mean±SEM, n≥7). (L-R) BALF analysis at day 10 following bleomycin induced lung injury revealed no significant difference in BALF WBC, RBC, total protein, cell differential, or levels of CXCL1, CXCL10, and MCP-1 (mean±SEM, n≥7).</p
<p>Mice (n = 8 in each genotype) were intratracheally administered with bleomycin. Left lungs were f...
<p>Note. BALF = bronchoalveolar lavage fluid; IL1β = interleukin-1beta. Mice were treated with glybu...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
<p>There was more inflammatory infiltration at day 10 and fibrosis at day 21 post-bleomycin for doub...
<p><b>A</b>: TGFβ increases after bleomycin-induced lung injury only in wildtype mice, whereas knock...
<p>The numbers of BALF inflammatory cells increased after either a single (<b>A</b>) or repetitive (...
<p>(A) Representative H&E (top) and picrosirius red (bottom) images of lung sections (20X) from Cre-...
<p>A panel of cytokines and chemokines was examined in the plasma, lung homogenate and BALF of uninf...
<p>The CSF-1 receptor inhibitor BLZ945 (200 mg/kg, open circles), vehicle (20% Captisol) (closed cir...
The sensitivity to the fibrosis-inducing effect of bleomycin varies considerably from species to spe...
<p>Samples from BAL extracts (A) and whole lung homogenates (B) were analyzed via protein array to d...
<p>Representative results of H&E staining of lung tissue from mice in the bleomycin-induced lung inj...
<p>S1P concentration in BALF collected on the seventh day after intratracheal administration of bleo...
<p>Animals were treated with 0.1 mg/kg bleomycin (n = 9) or vehicle (n = 5) on six consecutive days ...
<p>Mice were intratracheally administered with bleomycin (n = 14−15) or PBS (n = 12) were assessed. ...
<p>Mice (n = 8 in each genotype) were intratracheally administered with bleomycin. Left lungs were f...
<p>Note. BALF = bronchoalveolar lavage fluid; IL1β = interleukin-1beta. Mice were treated with glybu...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
<p>There was more inflammatory infiltration at day 10 and fibrosis at day 21 post-bleomycin for doub...
<p><b>A</b>: TGFβ increases after bleomycin-induced lung injury only in wildtype mice, whereas knock...
<p>The numbers of BALF inflammatory cells increased after either a single (<b>A</b>) or repetitive (...
<p>(A) Representative H&E (top) and picrosirius red (bottom) images of lung sections (20X) from Cre-...
<p>A panel of cytokines and chemokines was examined in the plasma, lung homogenate and BALF of uninf...
<p>The CSF-1 receptor inhibitor BLZ945 (200 mg/kg, open circles), vehicle (20% Captisol) (closed cir...
The sensitivity to the fibrosis-inducing effect of bleomycin varies considerably from species to spe...
<p>Samples from BAL extracts (A) and whole lung homogenates (B) were analyzed via protein array to d...
<p>Representative results of H&E staining of lung tissue from mice in the bleomycin-induced lung inj...
<p>S1P concentration in BALF collected on the seventh day after intratracheal administration of bleo...
<p>Animals were treated with 0.1 mg/kg bleomycin (n = 9) or vehicle (n = 5) on six consecutive days ...
<p>Mice were intratracheally administered with bleomycin (n = 14−15) or PBS (n = 12) were assessed. ...
<p>Mice (n = 8 in each genotype) were intratracheally administered with bleomycin. Left lungs were f...
<p>Note. BALF = bronchoalveolar lavage fluid; IL1β = interleukin-1beta. Mice were treated with glybu...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...